|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
|
|
|
|||||||||
|
|||||||||||
|
J Am Coll Cardiol, 2002; 39:1581-1587 © 2002 by the American College of Cardiology Foundation |
* Cardiovascular Research Foundation, New York, New York, USA
Scripps Clinic and Research Institute, La Jolla, California, USA
Jersey Shore Medical Center, Neptune, New Jersey, USA
Presbyterian Hospital, Oklahoma City, Oklahoma, USA
|| Cleveland Clinic Foundation, Cleveland, Ohio, USA
¶ St. Vincent’s Medical Center, Bridgeport, Connecticut, USA
# St. John’s Hospital and Memorial Medical Center, Springfield, Illinois, USA
** St. Francis Hospital, Lawrenceville, Pennsylvania, USA
Manuscript received December 28, 2001; revised manuscript received February 25, 2002, accepted February 27, 2002.
* Reprint requests and correspondence: Dr. Gregg W. Stone, The Cardiovascular Research Foundation, 55 East 59th Street, 6th Floor, New York, New York 10021, USA.
gstone{at}crf.org
OBJECTIVES: We sought to evaluate the safety and efficacy of percutaneous transmyocardial revascularization (PTMR) in patients with refractory angina caused by one or more chronic total occlusions (CTOs) of a native coronary artery.
BACKGROUND: Previous unblinded, randomized trials of PTMR in patients with end-stage coronary artery disease and refractory angina have demonstrated significant relief of angina and increased exercise duration. Whether such benefits would be realized in blinded patients with less extensive coronary artery disease is unknown.
METHODS: A total of 141 consecutive patients with class III or IV angina caused by one or more chronically occluded native coronary arteries in which a percutaneous coronary intervention (PCI) had failed were prospectively randomized, at 17 medical centers, in the same procedure, to PTMR plus maximal medical therapy (MMT) (n = 71) or MMT only (n = 70). Blinding was achieved through heavy sedation, dark goggles and the concurrent performance of PCI in all patients.
RESULTS: Baseline characteristics were similar between the two groups. A median number of 20 laser channels were created in patients randomized to PTMR. At six months, the anginal class improved by two or more classes in 49% of patients assigned to PTMR and in 37% of those assigned to MMT (p = 0.33). The median increase in exercise duration from baseline to six months was 64 s with PTMR versus 52 s with MMT (p = 0.73). There were no differences in the six-month rates of death (8.6% vs. 8.8%), myocardial infarction (4.3% vs. 2.9%) or any revascularization (4.3% vs. 5.9%) in the PTMR and MMT groups, respectively (p = NS for all).
CONCLUSIONS: In patients with class III or IV angina caused by nonrecanalizable CTOs, the performance of PTMR does not result in a greater reduction in angina, improvement in exercise duration or survival free of adverse cardiac events, as compared with MMT only.
| ||||||||||||||||||
This article has been cited by other articles:
|
|
 |
|
  K. A. Horvath and Y. Zhou Transmyocardial Laser Revascularization and Extravascular Angiogenetic Techniques to Increase Myocardial Blood Flow Card. Surg. Adult, January 1, 2008; 3(2008): 733 - 752. [Full Text]
|
|
|
|
 |
|
 G. A Lanza Alternative treatments for angina Heart, May 1, 2007; 93(5): 544 - 546. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Tasse and R. Arora Transmyocardial Revascularization: Peril and Potential Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2007; 12(1): 44 - 53. [Abstract] [PDF]
|
|
|
|
 |
|
 D. McNab, S. N. Khan, L. D. Sharples, J. Y. Ryan, C. Freeman, N. Caine, S. Tait, I. Hardy, and P. M. Schofield An open label, single-centre, randomized trial of spinal cord stimulation vs. percutaneous myocardial laser revascularization in patients with refractory angina pectoris: the SPiRiT trial Eur. Heart J., May 1, 2006; 27(9): 1048 - 1053. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. B. Leon, R. Kornowski, W. E. Downey, G. Weisz, D. S. Baim, R. O. Bonow, R. C. Hendel, D. J. Cohen, E. Gervino, R. Laham, et al. A Blinded, Randomized, Placebo-Controlled Trial of Percutaneous Laser Myocardial Revascularization to Improve Angina Symptoms in Patients With Severe Coronary Disease J. Am. Coll. Cardiol., November 15, 2005; 46(10): 1812 - 1819. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Rott Advantage of percutaneous coronary intervention over medical therapy in angina relief and the placebo effect J. Am. Coll. Cardiol., January 18, 2005; 45(2): 327 - 328. [Full Text] [PDF]
|
|
|
|
 |
|
 W. P. Silver, R. A. Creighton, I. K. Triantafillopoulos, A. C. Devkota, P. S. Weinhold, and S. G. Karas Thermal Microdebridement Does Not Affect the Time Zero Biomechanical Properties of Human Patellar Tendons Am. J. Sports Med., December 1, 2004; 32(8): 1946 - 1952. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 N. Svorkdal Treatment of Inoperable Coronary Disease and Refractory Angina: Spinal Stimulators, Epidurals, Gene Therapy, Transmyocardial Laser, and Counterpulsation Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2004; 8(1): 43 - 58. [Abstract] [PDF]
|
|
|
|
|
|
U. Thadani Current Medical Management of Chronic Stable Angina Journal of Cardiovascular Pharmacology and Therapeutics, March 1, 2004; 9(1_suppl): S11 - S29. [Abstract] [PDF]
|
|
|
|
 |
|
 J. F. Beek, J. A. P. van der Sloot, M. Huikeshoven, H. J. Verberne, B. L. F. van Eck-Smit, J. van der Meulen, J. G. P. Tijssen, M. J. C. van Gemert, and R. Tukkie Cardiac denervation after clinical transmyocardial laser revascularization: Short-term and long-term iodine 123-labeled meta-iodobenzylguanide scintigraphic evidence J. Thorac. Cardiovasc. Surg., February 1, 2004; 127(2): 517 - 524. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Berger Ranolazine and Other Antianginal Therapies in the Era of the Drug-Eluting Stent JAMA, January 21, 2004; 291(3): 365 - 367. [Full Text] [PDF]
|
|
|
|
|
|
M. Saririan and M. J. Eisenberg Myocardial laser revascularization for the treatment of end-stage coronary artery disease J. Am. Coll. Cardiol., January 15, 2003; 41(2): 173 - 183. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. W. Stone and P. S. Teirstein Reply J. Am. Coll. Cardiol., December 4, 2002; 40(11): 2062 - 2063. [Full Text] [PDF]
|
|
|
|
|
|
E. C. Perin, S. J. DeMaio, B. George, and W. W. O'Neill Percutaneous laser revascularization in patients with chronic total occlusions J. Am. Coll. Cardiol., December 4, 2002; 40(11): 2062 - 2062. [Full Text] [PDF]
|
|
|
|
 |
|
 Transmyocardial Laser Revascularization Fails to Improve Angina Journal Watch Cardiology, July 12, 2002; 2002(712): 1 - 1. [Full Text]
|
|
| HOME | SUBSCRIPTIONS | CURRENT ISSUE | PAST ISSUES | CARDIOSOURCE | SEARCH | HELP | FEEDBACK |
